Evidence map›Paper›PMID 34202963›Full record

ArticleBiology2021

Analysing Parallel Strategies to Alter the Host Specificity of Bacteriophage T7.

Ákos Avramucz, Christian Møller-Olsen, Aurelija M Grigonyte, Yanahan Paramalingam, Andrew Millard, Antonia P Sagona, Tamás Fehér

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Identification and functional characterization of a novelFrontiers in cellular and infection microbiology · 2025
    Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Ákos AvramuczSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network (ELKH), 6726 Szeged, Hungary.
Christian Møller-OlsenSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.
Aurelija M GrigonyteSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.
Yanahan ParamalingamSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.
Andrew MillardDepartment Genetics and Genome Biology, University of Leicester, Leicester LE1 7RH, UK.
Antonia P SagonaSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, UK.ORCID 0000-0002-0386-2322
Tamás FehérSynthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network (ELKH), 6726 Szeged, Hungary.ORCID 0000-0001-9318-3640
University of Warwick · GBHUN-REN Szegedi Biológiai Kutatóközpont · HUUniversity of Leicester · GBUniversity of Szeged · HU

Funding

Biological Sciences Research Council (BBSRC) Future Leader Fellowship ref. BB/N011872/1Biotechnology and Biological Sciences Research Council (BBSRC) and University of Warwick funded Midlands Integrative Biosciences Training Partnership (MIBTP) BB/M01116X/1National Research, Development, and Innovation Office of Hungary (NKFIH) Grant No. K119298
6 · The paper itself

Abstract

The recognition and binding of host bacteria by bacteriophages is most often enabled by a highly specific receptor-ligand type of interaction, with the receptor-binding proteins (RBPs) of phages being the primary determinants of host specificity. Specifically modifying the RBPs could alter or extend the host range of phages otherwise exhibiting desired phenotypic properties. This study employed two different strategies to reprogram T7 phages ordinarily infecting commensal K12

Indexed as

bacteriophageBREDhost rangehost specificityphageRBPtail fibres

Identifiers

PMID34202963
PMCPMC8234382
OpenAlexW3177024374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.